NRx Pharmaceuticals
Dr. Harry Peled is the Medical director of Cardiology and Critical Care at Saint Jude medical center in Fullerton, California. In addition to being board-certified in cardiology and critical care he is also board-certified in geriatrics, palliative care and Neurocritical care. He graduated from Albert Einstein College of Medicine with special distinction for research. He has authored work published In the New England Journal of Medicine, Chest, Annals of internal medicine, and many others. He also holds a masters in bio ethics and health policy from Loyola University.
This person is not in the org chart
This person is not in any offices
NRx Pharmaceuticals
NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.